Audible. Prime Member exclusive offer. First 3 months free, $14.95 a month after 3 months. Cancel anytime. Offer ends July 31, 2024, 11:59 PM PT. Get this deal

2024 Biopharma Investment Outlook with Chris Dokomajilar
Feb 12 2024
Length: 19 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

2024 Biopharma Investment Outlook with Chris Dokomajilar

Listen for free

View show details

Summary
Our guest in this podcast episode is Chris Dokomajilar, Founder and CEO of DealForma. DealForma’s comprehensive life science database includes meticulously researched licensing deal financial comps, up-to-date profiles, and historic company and pipeline data. In this special spotlight episode, we take a deeper dive into the investment landscape for advanced therapies and also AI investment and partnership activity in the biopharma space.

Show more Show less

Show more Show less

What listeners say about 2024 Biopharma Investment Outlook with Chris Dokomajilar

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon